Kutheni oogqirha bavavanya la manqindi emva kokulahlekelwa ngokuphindaphindiweyo
Ukuba uye wavavanya uvavanyo lwe-lupus anticoagulant antibodies, mhlawumbi ufuna ukwazi ukuba kuya kuba nantoni na ukukhulelwa okanye ukuba imeko leyo idlala indima ekuhambeni kwexesha elidlulileyo .
Ulungele ukuqonda kwakho oku kuxilongwa ngoku kuhlaziywa, okubandakanya ingozi kunye nokwenyango olwenokwenzeka kule mqathango.
Ziziphi iindlela zokuvavanya
I-Lupus antiticoagulant antibodies ingomnye wamakishi omzimba we- antiphospholipid syndrome , isifo apho umzimba udala amanqindi omzimba ngokumelene ne-phospholipids (iziqhelo eziqhelekileyo zeeseli zegazi zabantu).
Ngako oko, i-lupus anticoagulant kunye nezinye i-antiphospholipid antibodies zingenza amacandelo amancinci egazi angakhokelela ekukhuseleni ukukhulelwa, kuquka ukukhulelwa komzimba.
Umntu akayi kuba neempawu zokuba ne-lupus anticoagulant antibodies kodwa unokuba nokuphuphuma kwesisu okanye i-blood clots.
Uvavanyo lwee-Antibodies zeLupus Anticoagulant
Oogqirha abavanyeli ngokuthe ngqo kwi-lupus anticoagulants kodwa benze ukuxilongwa kusekelwe kwiziphumo zenye okanye ngaphezulu kwezi zi vavanyo zelabhoratri:
- Ixesha lePartial Thromboplastin (PTT)
- Uvavanyo lokuhlaziya okanye ukuguqulwa kweVuser Viper Venom Test (dRVVT okanye MRVVT)
- Ixesha leProthrombin (PT)
- Isikhathi sokuvala i-Kaolin Plasma Clotting Time (KCT)
Ukuba iimvavanyo zibuya ngexabiso elingaqhelekanga, ugqirha wakho unokuyalela iimvavanyo zokulandelela ukuqinisekisa ukungaqhelekanga kwaye uqiniseke ukuba iziphumo ezingavumelekanga azibanga ngenxa yokungcola kwilebhu okanye ezinye izinto ezingaqhelekanga.
Ukutshatyalaliswa komtshato kuyinto ephazamisayo kubafazi abanethemba lokuba ngumama.
Abasetyhini abaninzi bafuna iimpendulo sokuba kutheni bafumana ukulahleka okukhulelweyo kokukhulelwa. Nangona ukufunyanwa kwamagciwane omzimba we-lupus anticoagulant kunokunika iimpendulo kubafazi abathile, abanye baya kuvavanya i-negative for these antibodies kwaye baphinda bafune iimpendulo malunga nokuba bangakwazi ukuthwala umntwana kwixesha.
Ngelishwa, abanye balaba bafazi abanakuze bafumane iimpendulo abazifunayo.
Abanye baya kuqhubeka benomsebenzi wegazi owenziwe ekufuneni kwabo inkcazo.
Ukuba uvavanya uvavanyo lwe-lupus anticoagulant antibodies, nangona kunjalo, ugqirha uya kukuxelela amanyathelo alandelayo ongayithatha.
Unyango lwabafazi abane-Lupus Anticoagulant Antibodies
Ngaphandle kwegama, abantu abane-antibodiesal lupus anticoagulant ayinayo i-systemic lupus erythematosus, i-disorder iyaziwa ngokuba yi-lupus, nangona abantu abane-disorder bangaba ne-lupus antiticoagulants. Ama-antibodies aseLupus anticoagulant angenzeka kubantu abaneentlobo ezininzi zezifo ezingafihliyo kodwa kungenzeka nakwabo abangenayo isizathu esaziwayo.
Ukuba ufumene ukuxilongwa kwe-lupus anticoagulant antibodies (okanye i-antiphospholipid syndrome) ukusuka kwi-OB / GYN njengenxalenye yokuvavanywa kokuphuphuma kwesisu , qiniseka ukuba ubuze ugqirha wakho nokuba unokufuna ukulandelelana nodokotela jikelele okanye ingcali yokubeka iliso.
Kubasetyhini abanokuxilongwa nge-antiphospholipid syndrome ngenxa ye-lupus antiticoagulants, ukunyango kubakho i-dose ephantsi okanye "umntwana" i-aspirin okanye ii- heparin ngexesha lokukhulelwa. Olu unyango lubonakala luphucula imiphumo yesiphumo esihle sokukhulelwa.
Thetha noogqirha malunga neendlela zokonyango ezikhoyo kuwe kwaye ukuba ucinga ukuba ezi zonyango ziya kukuvumela ukuba uthwale umntwana kwixesha.
Buza ugqirha wakho ukuba unayo nayiphi na imeko yonyango eya kwenza kube nzima kuwe ukuba ukhulelwe ngokuphumelelayo kwaye ziphi iimvavanyo okanye iimvavanyo ezingavumelana nale miqathango.
Imithombo:
Umbutho waseMelika weKlinikhi yeKliniki, "uLupus Anticoagulant: Ngethuba." I-LabTestsOnline 23 Meyi 2007.
U-Empson, M., M. Lassere, J. Craig, kunye noJ. Scott, "Ukuthintela ukuphuphuma kwesisu ngokuphindaphindiweyo kubafazi abane-antiphospholipid antibody okanye i-lupus anticoagulant." I-Cochrane Database yeeNkqubo zoVikethi 2005.
I-Lupus Anticoagulant Party Party, "Izikhokelo zokuvavanya i-lupus anticoagulant." Umbhalo we-Clinical Pathology 1991: 885-89.